Search | WHO COVID-19 Research Database

Response to: 'Can telerheumatology improve rheumatic and musculoskeletal disease service delivery in sub-Saharan Africa?' by Akpabio et al.

Caso, Francesco; Del Puente, Antonio; Girolimetto, Nicolò; Tasso, Marco; Caso, Corrado; Scarpa, Raffaele; Costa, Luisa.

Ann Rheum Dis ; 81(8): e143, 2022 08.

Article in English | MEDLINE | ID: covidwho-1932638

Subject(s)

Musculoskeletal Diseases , Rheumatic Diseases , Rheumatology , Africa South of the Sahara/epidemiology , Humans , Musculoskeletal Diseases/therapy , Rheumatic Diseases/therapy

Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: a population-based study.

Salvarani, Carlo; Bajocchi, Gianluigi; Mancuso, Pamela; Galli, Elena; Muratore, Francesco; Boiardi, Luigi; Catanoso, Mariagrazia; Pipitone, Nicolò; Cassone, Giulia; Girolimetto, Nicolò; Croci, Stefania; Cimino, Luca; Gradellini, Federeica; Beltrami, Marina; Di Lernia, Vito; Dolci, Giovammi; Massari, Marco; Marata, Anna Maria; Costantini, Massimo; Giorgi Rossi, Paolo.

Ann Rheum Dis ; 79(7): 986-988, 2020 07.

Article in English | MEDLINE | ID: covidwho-435835

Subject(s)

Antirheumatic Agents/therapeutic use , Coronavirus Infections/epidemiology , Hospitalization/statistics & numerical data , Pneumonia, Viral/epidemiology , Rheumatic Diseases/drug therapy , Abatacept/therapeutic use , Adult , Aged , Antibodies, Monoclonal, Humanized/therapeutic use , Azetidines/therapeutic use , Betacoronavirus , COVID-19 , Coronavirus Infections/physiopathology , Disease Susceptibility , Female , Humans , Interleukin 1 Receptor Antagonist Protein/therapeutic use , Italy/epidemiology , Janus Kinase Inhibitors/therapeutic use , Logistic Models , Male , Middle Aged , Pandemics , Piperidines/therapeutic use , Pneumonia, Viral/physiopathology , Proportional Hazards Models , Purines , Pyrazoles , Pyrimidines/therapeutic use , Pyrroles/therapeutic use , Risk Factors , SARS-CoV-2 , Severity of Illness Index , Sulfonamides/therapeutic use , Tumor Necrosis Factor Inhibitors/therapeutic use , Ustekinumab/therapeutic use

Telerheumatology in COVID-19 era: a study from a psoriatic arthritis cohort.

Costa, Luisa; Tasso, Marco; Scotti, Nadia; Mostacciuolo, Erika; Girolimetto, Nicolò; Foglia, Francesca; Del Puente, Antonio; Scarpa, Raffaele; Caso, Francesco.

Ann Rheum Dis ; 80(4): e46, 2021 04.

Article in English | MEDLINE | ID: covidwho-594843

Subject(s)

Antirheumatic Agents , Arthritis, Psoriatic , COVID-19 , Antirheumatic Agents/therapeutic use , Arthritis, Psoriatic/drug therapy , Cohort Studies , Etanercept/therapeutic use , Humans , Treatment Outcome , Tumor Necrosis Factor-alpha

Subject(s)

Subject(s)

Subject(s)

SEND TO:

SELECTION OF CITATIONS

SEARCH DETAIL